| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TRxADE HEALTH, INC | Director | Common stock | 75.7K | $81.7K | $1.08 | Sep 1, 2022 | Direct |
| Aspire Biopharma Holdings, Inc. | Director | Common Stock, par value $0.0001 | 20K | $7.8K | $0.39 | Jun 5, 2025 | Direct |